Placement Announcement

We're thrilled to announce the successful placement of Dr. David Liebowitz [tag] as Chief Medical Officer at Avacta Therapeutics[tag], a clinical-stage biotech company revolutionizing cancer treatment through innovative peptide drug conjugates.

Dr. Liebowitz brings exceptional expertise to lead Avacta's clinical strategy at this crucial moment. His leadership will be instrumental in advancing Avacta's revolutionary drug delivery system, which minimizes toxic side effects while maximizing therapeutic impact through tumor-specific targeting.

The alignment of exceptional leadership with transformative science remains one of the most compelling forces in biotechnology, especially when it holds the promise of revolutionizing oncology and creating new possibilities for cancer patients globally.

Congratulations to Dr. Liebowitz [tag] on this exciting new chapter, and to the entire Avacta [tag] team on securing such exceptional leadership and talent for their important work.

Read the full announcement here: https://avacta.com/avacta-appoints-david-liebowitz-m-d-ph-d-as-chief-medical-officer-and-yulii-bogatyrenko-as-advisor-in-business-development/

#Avacta #HarmoniaBioSearch #Biotech #Oncology #ExecutiveSearch #CancerResearch